ADRIAC-36

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameADRIAC-36
Drug Alias Nametargeted endonuclease-based biotherapeutic (Adriacell Pharmaceuticals)ADRIAC-36CROMOC-36
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionApoptosis stimulantsEndonucleases modulators
TargetsEndonucleases
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdriacell Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdriacell Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A